A carregar...

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Atacicept in a Randomized Trial in Healthy Caucasian and Japanese Subjects

BACKGROUND AND OBJECTIVE: Atacicept is an inhibitor of the B lymphocyte stimulator (BLyS) and a proliferation-inducing ligand (APRIL), and is being studied in relation to immunological disease. Currently, limited data on atacicept are available in non-Caucasian subjects. Pharmacokinetic data from ea...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Drug Metab Pharmacokinet
Main Authors: Willen, Daniela, Uhl, Wolfgang, Wolna, Peter, Papasouliotis, Orestis, Yalkinoglu, Özkan
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6994531/
https://ncbi.nlm.nih.gov/pubmed/31529406
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13318-019-00575-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!